Published in Virology on February 01, 1999
Transcriptional regulation of human small nuclear RNA genes. Biochim Biophys Acta (2008) 1.25
Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF. Mol Cell Biol (2000) 1.25
Specific chromosome 1 breaks induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2000) 1.21
The p53 tumor suppressor protein represses human snRNA gene transcription by RNA polymerases II and III independently of sequence-specific DNA binding. Mol Cell Biol (2005) 1.10
Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx. J Virol (2003) 1.08
E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53. J Virol (2000) 1.04
HCMV-infected cells maintain efficient nucleotide excision repair of the viral genome while abrogating repair of the host genome. PLoS Pathog (2012) 0.99
Sequestration of p53 in the cytoplasm by adenovirus type 12 E1B 55-kilodalton oncoprotein is required for inhibition of p53-mediated apoptosis. J Virol (2003) 0.92
Biophysical and functional analyses suggest that adenovirus E4-ORF3 protein requires higher-order multimerization to function against promyelocytic leukemia protein nuclear bodies. J Biol Chem (2012) 0.85
Human U2 snRNA genes exhibit a persistently open transcriptional state and promoter disassembly at metaphase. Mol Cell Biol (2008) 0.83
Inhibition of p53 by adenovirus type 12 E1B-55K deregulates cell cycle control and sensitizes tumor cells to genotoxic agents. J Virol (2011) 0.81
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection. Cell Cycle (2012) 0.77
Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information. Annu Rev Biochem (1986) 11.03
A compensatory base change in U1 snRNA suppresses a 5' splice site mutation. Cell (1986) 9.65
Amino-terminal sequence analysis of proteins purified on a nanomole scale by gel electrophoresis. J Biol Chem (1972) 5.24
Direct repeats flank three small nuclear RNA pseudogenes in the human genome. Cell (1981) 4.53
A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev (1989) 3.79
Formation of the 3' end of U1 snRNA requires compatible snRNA promoter elements. Cell (1986) 3.69
Natural read-through at the UGA termination signal of Q-beta coat protein cistron. Nat New Biol (1971) 3.52
An abundant cytoplasmic 7S RNA is complementary to the dominant interspersed middle repetitive DNA sequence family in the human genome. Cell (1980) 3.45
Pseudogenes for human small nuclear RNA U3 appear to arise by integration of self-primed reverse transcripts of the RNA into new chromosomal sites. Cell (1983) 3.12
Upstream sequences modulate the internal promoter of the human 7SL RNA gene. Nature (1985) 2.97
Orientation-dependent transcriptional activator upstream of a human U2 snRNA gene. Mol Cell Biol (1985) 2.87
Abundant pseudogenes for small nuclear RNAs are dispersed in the human genome. Proc Natl Acad Sci U S A (1981) 2.66
Sequences required for 3' end formation of human U2 small nuclear RNA. Cell (1985) 2.57
Human genes for U2 small nuclear RNA are tandemly repeated. Mol Cell Biol (1984) 2.52
Dictyostelium small nuclear RNA D2 is homologous to rat nucleolar RNA U3 and is encoded by a dispersed multigene family. Cell (1980) 2.33
Evidence for base-pairing between mammalian U2 and U6 small nuclear ribonucleoprotein particles. Genes Dev (1990) 2.26
Genetic evidence for base pairing between U2 and U6 snRNA in mammalian mRNA splicing. Nature (1991) 2.24
UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc Natl Acad Sci U S A (1989) 2.22
Human U2 small nuclear RNA genes contain an upstream enhancer. EMBO J (1986) 2.10
Human genes and pseudogenes for the 7SL RNA component of signal recognition particle. EMBO J (1984) 2.05
The 5' end of U3 snRNA can be crosslinked in vivo to the external transcribed spacer of rat ribosomal RNA precursors. J Mol Biol (1989) 2.05
Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients. Cancer Res (1984) 2.01
Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a. J Pediatr (1991) 1.98
Human U1 RNA pseudogenes may be generated by both DNA- and RNA-mediated mechanisms. Mol Cell Biol (1982) 1.89
Distinct factors with Sp1 and NF-A specificities bind to adjacent functional elements of the human U2 snRNA gene enhancer. Genes Dev (1987) 1.85
Hairpin properties of single-stranded DNA containing a GC-rich triplet repeat: (CTG)15. Nucleic Acids Res (1995) 1.84
Hepatocellular carcinoma screening practices and impact on survival among hepatitis B-infected Asian Americans. J Viral Hepat (2012) 1.79
Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol (2000) 1.79
CCA addition by tRNA nucleotidyltransferase: polymerization without translocation? EMBO J (1998) 1.71
Association of snRNA genes with coiled bodies is mediated by nascent snRNA transcripts. Curr Biol (1999) 1.70
An irregular satellite sequence is found at the termini of the linear extrachromosomal rDNA in Dictyostelium discoideum. Cell (1981) 1.69
A single UGA codon functions as a natural termination signal in the coliphage q beta coat protein cistron. J Mol Biol (1973) 1.69
The natural 5' splice site of simian virus 40 large T antigen can be improved by increasing the base complementarity to U1 RNA. Mol Cell Biol (1987) 1.68
Normal lymphoid homeostasis and lack of lethal autoimmunity in mice containing mature T cells with severely impaired IL-2 receptors. J Immunol (2000) 1.58
The use of consensus guidelines for management of cytomegalovirus infection in renal transplantation. Kidney Int (2007) 1.57
Phylogeny from function: evidence from the molecular fossil record that tRNA originated in replication, not translation. Proc Natl Acad Sci U S A (1994) 1.55
Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity. J Clin Invest (1997) 1.51
Structural and functional analysis of hypoxia-inducible factor 1. Kidney Int (1997) 1.48
Activation of p53 or loss of the Cockayne syndrome group B repair protein causes metaphase fragility of human U1, U2, and 5S genes. Mol Cell (2000) 1.46
Concerted evolution of the tandem array encoding primate U2 snRNA occurs in situ, without changing the cytological context of the RNU2 locus. EMBO J (1995) 1.45
Specific toxicity of 2-chlorodeoxyadenosine toward resting and proliferating human lymphocytes. Blood (1983) 1.43
Either gene amplification or gene conversion may maintain the homogeneity of the multigene family encoding human U1 small nuclear RNA. Cold Spring Harb Symp Quant Biol (1983) 1.42
Biomarkers in transplantation: Prospective, blinded measurement of predictive value for the flow cytometry crossmatch after negative antiglobulin crossmatch in kidney transplantation. Kidney Int (2006) 1.42
The trinucleotide repeat sequence d(CGG)15 forms a heat-stable hairpin containing Gsyn. Ganti base pairs. Biochemistry (1995) 1.42
5' terminal nucleotide sequences of the messenger RNA's of Dictyostelium discoideum. Cell (1976) 1.40
Pseudogenes for human U2 small nuclear RNA do not have a fixed site of 3' truncation. Nucleic Acids Res (1984) 1.33
The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene (2007) 1.32
The highly conserved U small nuclear RNA 3'-end formation signal is quite tolerant to mutation. Mol Cell Biol (1987) 1.32
Human genes for U2 small nuclear RNA map to a major adenovirus 12 modification site on chromosome 17. Nature (1985) 1.30
Genes and pseudogenes for rat U3A and U3B small nuclear RNA. J Mol Biol (1985) 1.27
Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol (1989) 1.27
Human U1 small nuclear RNA genes: extensive conservation of flanking sequences suggests cycles of gene amplification and transposition. Mol Cell Biol (1985) 1.27
Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma. N Engl J Med (1977) 1.22
The CCA-adding enzyme has a single active site. J Biol Chem (1998) 1.20
Collaboration between CC- and A-adding enzymes to build and repair the 3'-terminal CCA of tRNA in Aquifex aeolicus. Science (2001) 1.19
The small nuclear RNAs of the cellular slime mold Dictyostelium discoideum. Isolation and characterization. J Biol Chem (1981) 1.19
A top-half tDNA minihelix is a good substrate for the eubacterial CCA-adding enzyme. RNA (1998) 1.18
In-vitro measurement of static pressure distribution in synovial joints--Part II: Retropatellar surface. J Biomech Eng (1983) 1.18
Anti-peptide antibodies detect oncogene-related proteins in urine. Proc Natl Acad Sci U S A (1985) 1.18
U1 small nuclear RNA genes are subject to dosage compensation in mouse cells. Science (1985) 1.15
The role of recombinant platelet-activating factor acetylhydrolase in a neonatal rat model of necrotizing enterocolitis. Pediatr Res (1997) 1.15
Genetic analysis of the role of human U1 snRNA in mRNA splicing: I. Effect of mutations in the highly conserved stem-loop I of U1. Genes Dev (1989) 1.15
The conserved dinucleotide AG of the 3' splice site may be recognized twice during in vitro splicing of mammalian mRNA precursors. Gene (1990) 1.15
Human U1 small nuclear RNA pseudogenes do not map to the site of the U1 genes in 1p36 but are clustered in 1q12-q22. Mol Cell Biol (1985) 1.14
Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells. J Immunol (2001) 1.14
The phylogenetically invariant ACAGAGA and AGC sequences of U6 small nuclear RNA are more tolerant of mutation in human cells than in Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.12
Structure and evolution of the U2 small nuclear RNA multigene family in primates: gene amplification under natural selection? Mol Cell Biol (1990) 1.12
Femtosecond pulse sequences used for optical manipulation of molecular motion. Science (1990) 1.11
Large scale purification of A-protein from bacterior17. Eur J Biochem (1970) 1.11
A rapid method for determining the molecular weight of a protein bound to nucleic acid in a mobility shift assay. Nucleic Acids Res (1992) 1.08
Studies on the effect of specific antisera on the metabolism of cellular antigens. II. The synthesis and degradation of TL antigens of mouse cells in the presence of TL antiserum. J Immunol (1974) 1.08
Regulation of cardiovascular development and physiology by hypoxia-inducible factor 1. Ann N Y Acad Sci (1999) 1.06
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study. J Natl Cancer Inst (1997) 1.05
A novel U1/U5 interaction indicates proximity between U1 and U5 snRNAs during an early step of mRNA splicing. RNA (1997) 1.05
The 'last ribo-organism' was no breakthrough. Nature (1988) 1.05
Frequent loss of the P16INK4a gene product in human pituitary tumors. Cancer Res (1996) 1.03
Multiscale carbon nanotube-carbon fiber reinforcement for advanced epoxy composites. Langmuir (2007) 1.02
Studies on common illnesses and medical care utilization patterns of adolescents in Hong Kong. J Adolesc Health (2000) 0.99
Xerostomia in diabetes mellitus. Diabetes Care (1992) 0.98
Lack of degeneration of loci on the neo-Y chromosome of Drosophila americana americana. Genetics (1997) 0.98
Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation. J Biol Chem (1999) 0.97
Studies on the effect of specific antisera on the metabolism of cellular antigens. I. Isolation of thymus leukemia antigens. J Immunol (1974) 0.97
A U1 small nuclear ribonucleoprotein particle with altered specificity induces alternative splicing of an adenovirus E1A mRNA precursor. Mol Cell Biol (1989) 0.97
Hodgkin's disease presenting in epitrochlear nodes. Med Pediatr Oncol (1984) 0.96
Adherence to combined Lamivudine + Zidovudine versus individual components: a community-based retrospective medicaid claims analysis. AIDS Care (2005) 0.96
Frequent inactivation of the p16 gene in human pituitary tumors by gene methylation. Mol Carcinog (1997) 0.96
Characterization of a novel class of interspersed LTR elements in primate genomes: structure, genomic distribution, and evolution. J Mol Evol (1998) 0.95
Assessment of total energy expenditure in a Chinese population by a physical activity questionnaire: examination of validity. Int J Food Sci Nutr (2001) 0.94
Cooperation between CCAAT and octamer motifs in the distal sequence element of the rat U3 small nucleolar RNA promoter. Nucleic Acids Res (1991) 0.93
Prevalence and correlates of physical abuse in Hong Kong Chinese adolescents: a population-based approach. Child Abuse Negl (1999) 0.93
Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res (2006) 0.93
Detection of methylthioadenosine phosphorylase (MTAP) and p16 gene deletion in T cell acute lymphoblastic leukemia by real-time quantitative PCR assay. Leukemia (2000) 0.92
Do all SINEs lead to LINEs? Nat Genet (2000) 0.92
Bioavailability of quercetin: problems and promises. Curr Med Chem (2013) 0.91
Picosecond pulse shaping by spectral phase and amplitude manipulation. Opt Lett (1985) 0.90
Programmable femtosecond pulse shaping by use of a multielement liquid-crystal phase modulator. Opt Lett (1990) 0.90